{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:02:42Z","timestamp":1765666962468},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jclinepi.2011.09.011","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T23:56:29Z","timestamp":1326844589000},"page":"444-453","source":"Crossref","is-referenced-by-count":15,"title":["Good interobserver agreement was attainable on outcome adjudication in patients with stable coronary heart disease"],"prefix":"10.1016","volume":"65","author":[{"given":"Erik","family":"Kjoller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorgen","family":"Hilden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Winkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niels J.","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soren","family":"Galatius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gorm","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorgen Fischer","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans J.","family":"Kolmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian M.","family":"Jespersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2011.09.011_bib1","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1001\/jama.289.19.2575","article-title":"Clinical trials\u2014multiple treatments, multiple end points, and multiple lessons","volume":"289","author":"Lauer","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib2","unstructured":"U.S. Department of Health and Human Services\u2014Food and Drug Administration. Guidance for Clinical Trial Sponsors Establishment and Operation of Clinical Trial Data Monitoring Committees. 2006:1\u201338. Available at http:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/ucm127073.pdf. Accessed November 13, 2011."},{"key":"10.1016\/j.jclinepi.2011.09.011_bib3","unstructured":"Committee for Medicinal Products for Human Use\u2014European Medicines Agency (EMA). Guideline on Data Monitoring Committees. 2005:1\u20138. Available at http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003635.pdf. Accessed November 13, 2011."},{"key":"10.1016\/j.jclinepi.2011.09.011_bib4","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jclinepi.2008.09.011","article-title":"Inadequate planning and reporting of adjudication committees in clinical trials: recommendation proposal","volume":"62","author":"Dechartres","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib5","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.jclinepi.2009.12.017","article-title":"Cardiovascular outcome ascertainment was similar using blinded and unblinded adjudicators in a national prospective study","volume":"63","author":"Parmar","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000022705","article-title":"Intervention with clarithromycin in patients with stable coronary heart disease: the CLARICOR trial design","volume":"1","author":"Hansen","year":"2001","journal-title":"Heart Drug"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.38666.653600.55","article-title":"Randomised placebo controlled multicentre trial to assess short term clarithromycin for patients with stable coronary heart disease: CLARICOR trial","volume":"332","author":"Jespersen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1159\/000128994","article-title":"Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease","volume":"111","author":"Gluud","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib9","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","article-title":"Myocardial infarction redefined\u2014a consensus document of The Joint European Society of Cardiology\/American College of Cardiology Committee for the redefinition of myocardial infarction","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib10","first-page":"741","article-title":"Guidelines for the diagnosis of heart failure. The Task Force on Heart Failure of the European Society of Cardiology","volume":"16","year":"1995","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib11","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/00365529209000166","article-title":"Observer homogeneity in the histologic diagnosis of Helicobacter pylori. Latent class analysis, kappa coefficient, and repeat frequency","volume":"27","author":"Christensen","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/1740774507087972","article-title":"Do we need to adjudicate major clinical events?","volume":"5","author":"Granger","year":"2008","journal-title":"Clin Trials"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1740774509105223","article-title":"Evaluating the benefit of event adjudication of cardiovascular outcomes in large simple RCTs","volume":"6","author":"Pogue","year":"2009","journal-title":"Clin Trials"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0197-2456(96)00131-6","article-title":"Outcome assessment for clinical trials: how many adjudicators do we need? Canadian Lung Oncology Group","volume":"18","author":"Walter","year":"1997","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/CVM-2-4-180","article-title":"Systematic adjudication of myocardial infarction end-points in an international clinical trial","volume":"2","author":"Mahaffey","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000224157","article-title":"The FDA prasugrel review: adjudication of myocardial infarction controversy","volume":"114","author":"Serebruany","year":"2009","journal-title":"Cardiology"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib18","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/080370502321095294","article-title":"The role of the critical event committee in a major cardiovascular outcome study","volume":"11","author":"Heagerty","year":"2002","journal-title":"Blood Press"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib19","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/euhj.1998.1351","article-title":"The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee\u2019s final decision on end-points","volume":"20","author":"Naslund","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib20","first-page":"127","article-title":"Blinded end point adjudication in the Danish Multicenter Randomized Study on Fibrinolytic Therapy versus Acute Coronary Angioplasty in Acute Myocardial Infarction (DANAMI-2 trial)","volume":"3","author":"Vejlstrup","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib21","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.cct.2007.04.001","article-title":"Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experience","volume":"28","author":"Kirwan","year":"2007","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/mhj.2002.120145","volume":"143","author":"Mahaffey","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/CVM-2-4-187","article-title":"Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study","volume":"2","author":"Mahaffey","year":"2001","journal-title":"Curr Control Trials Cardiovasc Med"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib24","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"issue":"9 suppl","key":"10.1016\/j.jclinepi.2011.09.011_bib25","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/S1047-2797(03)00048-6","article-title":"Outcomes ascertainment and adjudication methods in the Women\u2019s Health Initiative","volume":"13","author":"Curb","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib26","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cct.2006.02.002","article-title":"Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee","volume":"27","author":"Petersen","year":"2006","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.jclinepi.2011.09.011_bib27","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/thx.2006.072348","article-title":"Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee","volume":"62","author":"McGarvey","year":"2007","journal-title":"Thorax"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543561100312X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089543561100312X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T01:55:39Z","timestamp":1543283739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089543561100312X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S089543561100312X"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2011.09.011","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}